Thalidomide Induced Anemia in a Patient with Multiple Myeloma

Author(s)	Shikka Mary Mathew, Jacob Jesurun R.S, Rajesh Joseph, Harikrishnan. S, Swetha Reba Mathews
Country	India
Abstract	Thalidomide has been widely used in the treatment of various hematologic malignancies and inflammatory disorders. Here, we present a case of thalidomide induced anemia in a 65-year-old male patient diagnosed with multiple myeloma. This case underscores the importance of vigilance for hematological adverse effects in patients receiving thalidomide therapy and the need for close monitoring and prompt management.
Keywords	Thalidomide, anemia, adverse drug reaction, hematologic malignancy.
Field	Medical / Pharmacy
Published In	Volume 6, Issue 3, May-June 2024
Published On	2024-06-23
Cite This	Thalidomide Induced Anemia in a Patient with Multiple Myeloma - Shikka Mary Mathew, Jacob Jesurun R.S, Rajesh Joseph, Harikrishnan. S, Swetha Reba Mathews - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.23350
DOI	https://doi.org/10.36948/ijfmr.2024.v06i03.23350
Short DOI	https://doi.org/gt24z7

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research